Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shu Fei Tie is a Traditional Chinese Medicine (TCM) medicated patch used for acupoint application therapy, specifically designed to treat chronic airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is utilized according to the "winter disease being cared in summer" (Dong Bing Xia Zhi) principle, where the treatment is administered during the "Sanfu" (the three ten-day periods of the hottest season) to prevent winter recurrences. The formulation is a medical institution preparation developed by Guang'anmen Hospital, typically applied to specific acupuncture points to regulate immune function and reduce airway inflammation. Clinical studies, including large-scale randomized controlled trials, evaluate its efficacy in reducing the frequency of acute exacerbations and improving lung function and quality of life.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shu fei tie.